Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.03% | 139.92 | 0.6% | $754.74m | |
| PFE | Pfizer Inc. | 0.05% | 43.03 | 0.9% | $738.09m | |
| MRK | Merck & Co., Inc. | -0.64% | 69.97 | 0.6% | $453.44m | |
| ABBV | AbbVie, Inc. | 0.06% | 95.43 | 2.1% | $342.84m | |
| LLY | Eli Lilly and Company | 0.42% | 106.15 | 1.0% | $321.26m | |
| BMY | Bristol-Myers Squibb Company | 0.08% | 61.35 | 1.4% | $269.86m | |
| AZN | AstraZeneca PLC Sponsored ADR | -0.61% | 37.33 | 1.3% | $130.29m | |
| NVS | Novartis AG Sponsored ADR | -0.53% | 84.68 | 0.2% | $110.23m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.15% | 39.27 | 0.2% | $72.98m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.53% | 47.39 | 0.1% | $52.46m | |
| SNY | Sanofi Sponsored ADR | -0.28% | 43.63 | 0.2% | $44.01m | |
| LCI | Lannett Company, Inc. | -2.04% | 4.80 | 37.0% | $15.48m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 1.57% | 2.07 | 1.7% | $0.13m | |
| EPIX | ESSA Pharma Inc | 3.81% | 3.27 | 0.1% | $0.05m |
Company Profile
Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol. Shire was founded in 1986 and is headquartered in Dublin, Ireland.